WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Recruiting
Who can join
Ages 50 to 90 · All sexes
Full eligibility criteria
Inclusion Criteria: * 50-90 years old * Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia * Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission, Columbia Suicide Severity Rating Scale (CSSR-S) ≥ 2, "Non-specific Active Suicidal Thoughts." * We will also include patients on psychotropics and on after-care community psychotherapy. Exclusion Criteria: * Current diagnosis of Psychotic Disorders; Diagnosis of Dementia * Cognitive Impairment (MMSE ≤ 24) * Acute or severe medical illness (i.e., delirium; decompensated cardiac, liver or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry * Aphasia, sensory problems, and/or inability to speak English.
About the study
The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
What is being tested
- WellPATH-PREVENT (behavioral)
- Optimized WellPATH-PREVENT (behavioral)
Sponsor: Weill Medical College of Cornell University · Participants: 115 · Started: Apr 22, 2022
Contact the study team
- Dimitris Kiosses, PhD · Phone: 914-997-4381
- Laurie Evans, MS · Phone: 914-682-9100
Official record on ClinicalTrials.gov — NCT05183230
Locations in the U.S.
| New York | New York Presbyterian Hospital/Weill Cornell Medicine, New York (Not yet recruiting) Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.